| | | Ronald D. Berger, M.D., Ph.D., F.A.C.C. |
| | |
| | | Elizabeth Robinson, R.N. |
| | |
| | (410) 502 - 0517
|
| | |
| | erobin26@jhmi.edu
|
| | |
| | TTOP AF |
| | |
| | Tailored Treatment of Permanent Atrial Fibrillation Trial |
| | |
| | JH-eIRB #NA_00011212 |
| | |
| | Ablation Frontiers, Inc. |
| | |
| | To investigate the safety and efficacy of the Ablation Frontiers Cardiac Ablation System in the treatment of permanent atrial fibrillation. |
| | |
| | Age between 18 and 70 Patients with non-self-terminating AF lasting greater than seven (7) days but less than four (4) years with at least one failed DC cardioversion within the previous two years Failure of at least one class I or III rhythm control AAD |
| | |
| | Patients with structural heart disease Prior ASD or PFO closure with a device using a percutaneous approach Hypertrophic cardiomyopathy (LV septal wall thickness >1.5 cm) Any prior ablation for atrial fibrillation |
| | |
| | Johns Hopkins University
600 N. Wolfe Street, Carnegie 586
Baltimore, MD 21287 |
| | |
| | No, but parking passes will be distributed to assist with travel expenses. |
| | |
| | 2008 |
| | |
| | 2010 |
